Diagnostic performance of 18F-FACBC PET/CT, PET/MRI and MRI in primary prostate cancer

被引:0
|
作者
Kemppainen, J. [1 ]
Jambor, I. [1 ,2 ]
Kuisma, A. [3 ]
Kim, M. [1 ]
Ramadan, S. [3 ]
Eskola, O. [4 ]
Aronen, H. J. [2 ]
Kahkonen, E. [5 ]
Taimen, P. [6 ]
Minn, H. [1 ,3 ]
机构
[1] Turku Univ Hosp, Turku PET Ctr, Turku, Finland
[2] Turku Univ Hosp, Dept Radiol, Turku, Finland
[3] Turku Univ Hosp, Dept Oncol & Radiotherapy, Turku, Finland
[4] Univ Turku, Radiopharmaceut Chem Lab, Turku PET Ctr, Turku, Finland
[5] Turku Univ Hosp, Div Urol, Dept Surg, Turku, Finland
[6] Turku Univ Hosp, Dept Pathol, Turku, Finland
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OP354
引用
收藏
页码:S110 / S110
页数:1
相关论文
共 50 条
  • [1] 18F-FACBC PET/MRI in diagnostic assessment of gliomas
    Pedersen, L. K.
    NEURO-ONCOLOGY, 2022, 24
  • [2] 18F-FACBC PET/MRI in Diagnostic Assessment and Neurosurgery of Gliomas
    Karlberg, Anna
    Berntsen, Erik Magnus
    Johansen, Hakon
    Skjulsvik, Anne Jarstein
    Reinertsen, Ingerid
    Dai, Hong Yan
    Xiao, Yiming
    Rivaz, Hassan
    Borghammer, Per
    Solheim, Ole
    Eikenes, Live
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (07) : 550 - 559
  • [3] Diagnostic Value of 18F-FACBC PET/MRI in Brain Metastases
    Oen, Silje Kjarrnes
    Johannessen, Knut
    Pedersen, Lars Kjelsberg
    Berntsen, Erik Magnus
    Totland, Jon Andre
    Johansen, Hakon
    Bogsrud, Trond Velde
    Solheim, Tora S.
    Karlberg, Anna
    Eikenes, Live
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (12) : 1030 - 1039
  • [4] 18F-Fluciclovine (18F-FACBC) PET/CT or PET/MRI in gliomas/glioblastomas
    Albano, Domenico
    Tomasini, Davide
    Bonu, Marco
    Giubbini, Raffaele
    Bertagna, Francesco
    ANNALS OF NUCLEAR MEDICINE, 2020, 34 (02) : 81 - 86
  • [5] 18F-Fluciclovine (18F-FACBC) PET/CT or PET/MRI in gliomas/glioblastomas
    Domenico Albano
    Davide Tomasini
    Marco Bonù
    Raffaele Giubbini
    Francesco Bertagna
    Annals of Nuclear Medicine, 2020, 34 : 81 - 86
  • [6] Diagnostic Performance of PET/CT Using 18F-FACBC in Prostate Cancer: A Meta-Analysis
    Bin, Xu
    Yong, Shan
    Kong, Qing-Fang
    Zhao, Sun
    Zhang, Guang-Yuan
    Wu, Jian-Ping
    Chen, Shu-Qiu
    Zhu, Wei-Dong
    Pan, Ke-Hao
    Du, Mu-Long
    Chen, Ming
    FRONTIERS IN ONCOLOGY, 2020, 9
  • [7] Simultaneous 18F-FACBC PET/MRI for staging of high-risk prostate cancer.
    Elschot, Mattijs
    Selnaes, Kirsten
    Kruger-Stokke, Brage
    Storkersen, Oystein
    Tessem, May-Britt
    Willoch, Frode
    Bertilsson, Helena
    Moestue, Siver
    Bathen, Tone
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [8] Prospective evaluation of 18F-FACBC PET/CT and PET/MRI versus multiparametric MRI in intermediate- to high-risk prostate cancer patients (FLUCIPRO trial)
    Ivan Jambor
    Anna Kuisma
    Esa Kähkönen
    Jukka Kemppainen
    Harri Merisaari
    Olli Eskola
    Jarmo Teuho
    Ileana Montoya Perez
    Marko Pesola
    Hannu J. Aronen
    Peter J. Boström
    Pekka Taimen
    Heikki Minn
    European Journal of Nuclear Medicine and Molecular Imaging, 2018, 45 : 355 - 364
  • [9] Implications of 18F-FACBC uptake dynamics for PET/MRI in high-risk prostate cancer.
    Elschot, Mattijs
    Selnaes, Kirsten
    Kruger-Stokke, Brage
    Storkersen, Oystein
    Tessem, May-Britt
    Bertilsson, Helena
    Moestue, Siver
    Bathen, Tone
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [10] Prospective evaluation of 18F-FACBC PET/CT and PET/MRI versus multiparametric MRI in intermediate- to high-risk prostate cancer patients (FLUCIPRO trial)
    Jambor, Ivan
    Kuisma, Anna
    Kahkonen, Esa
    Kemppainen, Jukka
    Merisaari, Harri
    Eskola, Olli
    Teuho, Jarmo
    Perez, Ileana Montoya
    Pesola, Marko
    Aronen, Hannu J.
    Bostrom, Peter J.
    Taimen, Pekka
    Minn, Heikki
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (03) : 355 - 364